CN102297911B - High efficiency liquid chromatography method for separating blonanserin intermediate III from other intermediates - Google Patents
High efficiency liquid chromatography method for separating blonanserin intermediate III from other intermediates Download PDFInfo
- Publication number
- CN102297911B CN102297911B CN 201110196097 CN201110196097A CN102297911B CN 102297911 B CN102297911 B CN 102297911B CN 201110196097 CN201110196097 CN 201110196097 CN 201110196097 A CN201110196097 A CN 201110196097A CN 102297911 B CN102297911 B CN 102297911B
- Authority
- CN
- China
- Prior art keywords
- blonanserin
- intermedium
- liquid chromatograph
- intermediate iii
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- LOJBBLDAJBJVBZ-UHFFFAOYSA-N N#CCC(c(cc1)ccc1F)=O Chemical compound N#CCC(c(cc1)ccc1F)=O LOJBBLDAJBJVBZ-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
The invention discloses a high efficiency liquid chromatography method for separating blonanserin intermediate III from other intermediates. According to the method, a chromatographic column (250mm*4.6mm, 5mum) with octane silicane bonded silica gel as a filling agent is adopted; buffering solutions and organic modifiers with different proportions are adopted as mobile phases; and blonanserin intermediate III is rapidly separated from other intermediate impurities under normal temperature.
Description
Technical field
The invention belongs to and relate to a kind of high performance liquid chromatography, the high performance liquid chromatography separation method of especially a kind of blonanserin intermediate III and other intermedium.
Background technology
Blonanserin is a kind of anti-psychotropic agent, atypical anti-psychotropic agent, and compare the spinoff reaction with other anti-psychotropic agents few.Intermediate III molecular formula: C
17H
18OFN, chemistry (Z)-4-(4-fluorophenyl)-5,6,7,8 by name, 910-six hydrogen cyclooctane are [b] pyridine-2 (1H)-ketone also, needs the intermediate compound I of separation, and intermediate II, intermediate III structural formula are respectively:
Intermediate I
Intermediate II
Intermediate III
In order effectively to separate blonanserin intermediate III and other intermedium, accurately control the quality of blonanserin intermediate III, present also do not have a kind of high performance liquid chromatogram isocratic elution mode to realize effectively separating of blonanserin intermediate III and other intermedium.
Summary of the invention
The high performance liquid chromatography separation method that the purpose of this invention is to provide a kind of blonanserin intermediate III and other intermedium; Be implemented in the needs of its intermedium purity of control in the process of leading to the synthesising target compound blonanserin, thereby reach accurate control the blonanserin quality.
A kind of blonanserin intermediate III that the present invention relates to and the high performance liquid chromatogram separation method of other intermedium may further comprise the steps:
(1) it is an amount of to get the blonanserin sample, with organic solvent dissolution blonanserin sample, is mixed with every 1ml and contains
The sample solution of blonanserin 0.5mg~1.0mg;
(2) moving phase of liquid chromatograph is set, promptly the A pump is an organic modifiers, and the B pump is a buffer solution, stream
Moving phase: the volume ratio of buffer solution and organic modifiers is 55:45;
(3) the flow rate of mobile phase 0.6~1.2mL/min of liquid chromatograph is set, detects wavelength 224 ± 3nm,
And 20 ℃~40 ℃ of the column ovens that the liquid chromatograph chromatographic column is set;
(4) the sample solution 5-20 μ l that gets step (1) injects the liquid chromatograph that is provided with through step (2) (3), accomplishes
The blonanserin intermediate III is separated with other intermedium.
Further, the organic solvent of said step (1) is methyl alcohol or ethanol.
The flow velocity of said step (3) is 0.6~1.2mL/min, detects wavelength 224 ± 3nm.
It is the chromatographic column of filling agent that described liquid chromatograph adopts octane silane key and silica gel, the specification of chromatographic column
Be length 250mm, internal diameter 4.6mm, granularity 5 μ m.
The organic modifiers of said step (2) is acetonitrile or methyl alcohol.
The buffer solution of said step (2) is 0.1% phosphoric acid water or aqueous phosphatic.
It is the chromatographic column of filling agent that the present invention adopts octane silane key and silica gel, can effectively analyze and separate blonanserin intermediate III and other intermedium; Selection methyl alcohol is solvent, guarantees that sample can dissolve fully; Select sampling volume 10 μ L, improved the symmetry of chromatographic peak; Select flow velocity 1.0mL/min, can improve degree of separation; Selecting moving phase is organic modifiers acetonitrile and buffering solution 0.1% phosphoric acid water; Realization blonanserin intermediate III is separated with other intermedium fully; Thereby guaranteed the quality controllable of blonanserin intermedium and preparation thereof, realized the synthetic quality control with the preparation production run of blonanserin intermedium at the blonanserin medicine.
Description of drawings
Fig. 1 is embodiment 1 high-efficient liquid phase chromatogram;
Fig. 2 is embodiment 2 high-efficient liquid phase chromatograms;
Fig. 3 is embodiment 3 high-efficient liquid phase chromatograms.
Embodiment
Embodiment 1
Adopting Tianjin, island LC-20AT model high performance liquid chromatograph, Welch Materials brand octane silane key and silica gel is the chromatographic column of filling agent, and the specification of chromatographic column is length 250mm, internal diameter 4.6mm, granularity 5 μ m.
The high performance liquid chromatogram separation method of a kind of blonanserin intermediate III and other intermedium may further comprise the steps:
(1) gets blonanserin intermedium III and intermediate I, each 5mg of II respectively, place the 10mL volumetric flask, add dissolve with methanol and be diluted to scale, shake up, as need testing solution;
(2) moving phase of liquid chromatograph is set, promptly the A pump is an organic modifiers, and the B pump is a buffer solution, moving phase: the volume ratio of 0.1% phosphoric acid water and methyl alcohol is 55:45
(3) flow rate of mobile phase 0.6mL/min, the detection wavelength 223nm of liquid chromatograph are set, and liquid is set
20 ℃ of the column ovens of chromatography chromatographic column;
(4) the need testing solution 20 μ l that get step (1) inject the liquid chromatograph that is provided with through step (2) (3), and completion blonanserin intermedium III is separated with other intermedium, the record chromatogram, and the result sees accompanying drawing 1.
Retention time is the chromatographic peak that the chromatographic peak of 7.155min, 8.301min is respectively intermedium II, I among Fig. 1, and retention time is that 13.388min is the chromatographic peak of blonanserin intermedium III.The degree of separation of intermedium II and intermedium III reaches 15, meets fully that " 2010 editions Chinese pharmacopoeia degree of separation are not less than 1.5 regulation, show that blonanserin intermedium III can be issued to well at same chromatographic condition with other intermedium to separate.
Embodiment 2
Adopting Tianjin, island LC-20AT model high performance liquid chromatograph, Welch Materials brand octane silane key and silica gel is the chromatographic column of filling agent, and the specification of chromatographic column is length 250mm, internal diameter 4.6mm, granularity 5 μ m.
The high performance liquid chromatogram separation method of a kind of blonanserin intermediate III and other intermedium may further comprise the steps:
(1) gets blonanserin intermedium III and intermediate I, each 8mg of II respectively, place the 10mL volumetric flask, add dissolve with methanol and be diluted to scale, shake up, as need testing solution;
(2) moving phase of liquid chromatograph is set, promptly the A pump is an organic modifiers, and the B pump is a buffer solution, moving phase: the volume ratio of 0.1% phosphoric acid water and acetonitrile is 50:50
(3) flow rate of mobile phase 1.2mL/min, the detection wavelength 227nm of liquid chromatograph are set, and liquid is set
40 ℃ of the column ovens of chromatography chromatographic column;
(4) the need testing solution 5 μ l that get step (1) inject the liquid chromatograph that is provided with through step (2) (3), and completion blonanserin intermedium III is separated with other intermedium, the record chromatogram, and the result sees accompanying drawing 2.
Retention time is the chromatographic peak that the chromatographic peak of 5.970min, 6.898min is respectively intermedium II, I among Fig. 2, and retention time is that 9.605min is the chromatographic peak of blonanserin intermedium III.The degree of separation of intermedium II and intermedium III reaches 12, meets fully that " 2010 editions Chinese pharmacopoeia degree of separation are not less than 1.5 regulation, show that blonanserin intermedium III can be issued to well at same chromatographic condition with other intermedium to separate.
Embodiment 3
Adopting Tianjin, island LC-20AT model high performance liquid chromatograph, Welch Materials brand octane silane key and silica gel is the chromatographic column of filling agent, and the specification of chromatographic column is length 250mm, internal diameter 4.6mm, granularity 5 μ m.
The high performance liquid chromatogram separation method of a kind of blonanserin intermediate III and other intermedium may further comprise the steps:
(1) gets blonanserin intermedium III and intermediate I, each 10mg of II respectively, place the 10mL volumetric flask, add dissolve with methanol and be diluted to scale, shake up, as need testing solution;
(2) moving phase of liquid chromatograph is set, promptly the A pump is an organic modifiers, and the B pump is a buffer solution, and the volume ratio of moving phase 0.1% phosphoric acid water and acetonitrile is 55:45
(3) flow rate of mobile phase 1.2mL/min, the detection wavelength 227nm of liquid chromatograph are set, and liquid is set
25 ℃ of the column ovens of chromatography chromatographic column;
(4) the need testing solution 10 μ l that get step (1) inject the liquid chromatograph that is provided with through step (2) (3), and completion blonanserin intermedium III is separated with other intermedium, the record chromatogram, and the result sees accompanying drawing 3.
Retention time is the chromatographic peak that the chromatographic peak of 6.737min, 7.727min is respectively intermedium II, I among Fig. 3, and retention time is that 11.310min is the chromatographic peak of blonanserin intermedium III.The degree of separation of intermedium II and intermedium III reaches 16, meets fully that " 2010 editions Chinese pharmacopoeia degree of separation are not less than 1.5 regulation, show that blonanserin intermedium III can be issued to well at same chromatographic condition with other intermedium to separate.
Claims (1)
1. the high performance liquid chromatogram separation method of a blonanserin intermediate III and other intermedium may further comprise the steps:
(1) it is an amount of to get the blonanserin sample, with organic solvent dissolution blonanserin sample, is mixed with the sample solution that every 1ml contains blonanserin 0.5mg~1.0mg, and organic solvent is methyl alcohol or ethanol;
(2) moving phase of liquid chromatograph is set, promptly to adopt octane silane key and silica gel be the chromatographic column of filling agent to liquid chromatograph, and the specification of chromatographic column is length 250mm; Internal diameter 4.6mm, granularity 5 μ m, the A pump is an organic modifiers; Organic modifiers is acetonitrile or methyl alcohol; The B pump is a buffer solution, and buffer solution is 0.1% phosphoric acid water or aqueous phosphatic, moving phase: the volume ratio of buffer solution and organic modifiers is 55:45;
(3) the flow rate of mobile phase 0.6~1.2mL/min of liquid chromatograph is set, detects wavelength 224 ± 3nm, and 20 ℃~40 ℃ of the column ovens that the liquid chromatograph chromatographic column is set;
(4) the sample solution 5-20 μ l that gets step (1) injects the liquid chromatograph that is provided with through step (2) (3); Completion blonanserin intermediate III
is separated with other intermedium, and other intermedium is blonanserin intermediate compound I
and blonanserin intermediate II
.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110196097 CN102297911B (en) | 2011-08-10 | 2011-08-10 | High efficiency liquid chromatography method for separating blonanserin intermediate III from other intermediates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110196097 CN102297911B (en) | 2011-08-10 | 2011-08-10 | High efficiency liquid chromatography method for separating blonanserin intermediate III from other intermediates |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102297911A CN102297911A (en) | 2011-12-28 |
CN102297911B true CN102297911B (en) | 2012-12-12 |
Family
ID=45358472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110196097 Expired - Fee Related CN102297911B (en) | 2011-08-10 | 2011-08-10 | High efficiency liquid chromatography method for separating blonanserin intermediate III from other intermediates |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102297911B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101747273A (en) * | 2008-12-02 | 2010-06-23 | 浙江华海药业股份有限公司 | Preparing method of blonanserin intermediate |
CN102093289A (en) * | 2010-10-29 | 2011-06-15 | 常州华生制药有限公司 | New preparation method of Blonanserin intermediate |
-
2011
- 2011-08-10 CN CN 201110196097 patent/CN102297911B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101747273A (en) * | 2008-12-02 | 2010-06-23 | 浙江华海药业股份有限公司 | Preparing method of blonanserin intermediate |
CN102093289A (en) * | 2010-10-29 | 2011-06-15 | 常州华生制药有限公司 | New preparation method of Blonanserin intermediate |
Non-Patent Citations (2)
Title |
---|
HPLC法测定布南色林片的含量;朱彩燕等;《中国药师》;20101231;第13卷(第10期);第1473-1474页 * |
朱彩燕等.HPLC法测定布南色林片的含量.《中国药师》.2010,第13卷(第10期),第1473-1474页. |
Also Published As
Publication number | Publication date |
---|---|
CN102297911A (en) | 2011-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102936275B (en) | Method for separating and purifying impurities in sodium tanshinone IIA sulfonate crude drug | |
CN103760257A (en) | Method for separating and measuring aprepitant related substances by liquid chromatography | |
Wei et al. | Enantioseparation of lomefloxacin hydrochloride by high-speed counter-current chromatography using sulfated-β-cyclodextrin as a chiral selector | |
EP3009429B1 (en) | R type resveratrol dimer, preparation method therefor and use thereof in reducing blood sugar | |
CN105092721A (en) | High performance liquid chromatography detection analysis method for controlling ticagrelor isomer | |
CN101532996A (en) | Method for analyzing and separating levetiracetam by using HPLC method | |
CN102297911B (en) | High efficiency liquid chromatography method for separating blonanserin intermediate III from other intermediates | |
CN103760280A (en) | Method for separating and measuring asenapine intermediate related substances by liquid chromatography | |
CN102297910B (en) | Separation method of blonanserin intermediate IV and other intermediates by high performance liquid chromatography | |
CN102384946B (en) | By the method for high efficiency liquid chromatography for separating and determining Entecavir and diastereo-isomerism thereof | |
CN103113211A (en) | Splitting method for racemic 2-benzene propanoic acid | |
CN106483202A (en) | A kind of separation and the method measuring alitretinoin and isomer | |
CN106039766B (en) | A method of separation gambogicacid epimer | |
CN101393185B (en) | Method for analytically separating clopidogrel and enantiomer thereof by HPLC method | |
CN101929988A (en) | Method for detecting febuxostat-associated matters by using high performance liquid chromatography | |
CN106018573B (en) | Hydrochloric acid replaces the method for detecting purity than drawing west in a kind of TAS-102 | |
CN103207247A (en) | Method of separating and determining aliskiren intermediate and optical isomers thereof by using liquid chromatography | |
CN101609071A (en) | A kind of HPLC method analysis separates the method for ivabradine hydrochloride intermediate optical isomer | |
CN103570512A (en) | Method for separating guaiacol glyceryl ether enantiomer through simulated moving bed chromatography technology | |
CN103570565B (en) | Method for resolving fluoxetine through simulated moving bed chromatography | |
CN101328161B (en) | Method for separating and detecting nebivolol hydrochloride impurity by liquid phase chromatography | |
CN104326898A (en) | Chiral resolution method for racemic 2-phenylbutyric acid | |
CN104483419A (en) | Detection method of bortezomib intermediate | |
CN103788064A (en) | Simulated moving bed chromatographic separation method for omeprazole enantiomer | |
CN104655736A (en) | Analysis and detection method of L-thiazolidinyl-4-carboxylic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121212 Termination date: 20140810 |
|
EXPY | Termination of patent right or utility model |